These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23897441)

  • 1. Crystal arthritis. Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous gout.
    Buckland J
    Nat Rev Rheumatol; 2013 Sep; 9(9):506. PubMed ID: 23897441
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of chronic refractory tophaceous gout with erosions with pegloticase.
    Yeter KC; Ortiz EC; Arkfeld DG
    Int J Rheum Dis; 2013 Jun; 16(3):369-70. PubMed ID: 23981765
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease.
    Bacani AK; McCollough CH; Glazebrook KN; Bond JR; Michet CJ; Milks J; Manek NJ
    Rheumatol Int; 2012 Jan; 32(1):235-9. PubMed ID: 20016988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.
    Yokose C; Dalbeth N; Wei J; Nicolaou S; Simeone FJ; Baumgartner S; Fung M; Zhang Y; Choi HK
    Semin Arthritis Rheum; 2020 Feb; 50(1):54-58. PubMed ID: 31371194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
    Dalbeth N; Billington K; Doyle A; Frampton C; Tan P; Aati O; Allan J; Drake J; Horne A; Stamp LK
    Arthritis Rheumatol; 2019 Oct; 71(10):1739-1746. PubMed ID: 31081595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Debulking the urate load to feel better.
    Richette P
    J Rheumatol; 2012 Jul; 39(7):1311-3. PubMed ID: 22753797
    [No Abstract]   [Full Text] [Related]  

  • 8. Resolution of massive tophaceous gout with three urate-lowering drugs.
    Mejía-Chew C; Torres RJ; de Miguel E; Puig JG
    Am J Med; 2013 Nov; 126(11):e9-10. PubMed ID: 23978312
    [No Abstract]   [Full Text] [Related]  

  • 9. Pegloticase and the patient with treatment-failure gout.
    Dave AJ; Kelly VM; Krishnan E
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative treatment for chronic gout could relieve pain for thousands. The recently approved intravenous drug, pegloticase, may work when other treatments don't.
    Duke Med Health News; 2013 Jan; 19(1):3. PubMed ID: 23762971
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment failure gout.
    Ali S; Lally EV
    Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
    [No Abstract]   [Full Text] [Related]  

  • 12. Pegloticase for treating refractory chronic gout.
    George RL; Sundy JS
    Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate oxidase (rasburicase) for treatment of severe tophaceous gout.
    Vogt B
    Nephrol Dial Transplant; 2005 Feb; 20(2):431-3. PubMed ID: 15673692
    [No Abstract]   [Full Text] [Related]  

  • 14. Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with gout.
    Berhanu AA; Krasnokutsky S; Keenan RT; Pillinger MH
    Semin Arthritis Rheum; 2017 Jun; 46(6):754-758. PubMed ID: 27769591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-failure gout: a moving target.
    Edwards NL
    Arthritis Rheum; 2008 Sep; 58(9):2587-90. PubMed ID: 18759307
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained Response to Pegloticase Without Infusion Reactions Despite Multiple Lapses in Treatment in Patient With Severe Tophaceous Gout.
    Schmidt JN; Cunningham MA
    J Clin Rheumatol; 2021 Dec; 27(8S):S491-S494. PubMed ID: 31743263
    [No Abstract]   [Full Text] [Related]  

  • 17. New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.
    Schlesinger N
    Curr Rheumatol Rep; 2010 Apr; 12(2):130-4. PubMed ID: 20425022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of gout.
    Meltzler M
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24493155
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
    Biggers K; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in gout: pathogenesis, diagnosis, comorbidities, treatment].
    Soós B; Szamosi S; Benkő S; Paragh G; Szekanecz Z
    Orv Hetil; 2018 Oct; 159(40):1625-1636. PubMed ID: 30277413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.